DE3785136D1 - Arzneimittel zur inhibition von hautfalte. - Google Patents

Arzneimittel zur inhibition von hautfalte.

Info

Publication number
DE3785136D1
DE3785136D1 DE8787903569T DE3785136T DE3785136D1 DE 3785136 D1 DE3785136 D1 DE 3785136D1 DE 8787903569 T DE8787903569 T DE 8787903569T DE 3785136 T DE3785136 T DE 3785136T DE 3785136 D1 DE3785136 D1 DE 3785136D1
Authority
DE
Germany
Prior art keywords
hydroxy
halogen
different
same
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787903569T
Other languages
English (en)
Other versions
DE3785136T2 (de
Inventor
Dexter Lippman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Block Drug Co Inc
Original Assignee
Block Drug Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Block Drug Co Inc filed Critical Block Drug Co Inc
Application granted granted Critical
Publication of DE3785136D1 publication Critical patent/DE3785136D1/de
Publication of DE3785136T2 publication Critical patent/DE3785136T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Heat Treatment Of Steel (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE8787903569T 1986-05-05 1987-05-04 Arzneimittel zur inhibition von hautfalte. Expired - Lifetime DE3785136T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/859,464 US4695590A (en) 1986-05-05 1986-05-05 Method for retarding aging
PCT/US1987/001039 WO1987006829A1 (en) 1986-05-05 1987-05-04 Method for inhibiting aging

Publications (2)

Publication Number Publication Date
DE3785136D1 true DE3785136D1 (de) 1993-05-06
DE3785136T2 DE3785136T2 (de) 1993-08-05

Family

ID=25330990

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787903569T Expired - Lifetime DE3785136T2 (de) 1986-05-05 1987-05-04 Arzneimittel zur inhibition von hautfalte.

Country Status (8)

Country Link
US (1) US4695590A (de)
EP (1) EP0265514B1 (de)
JP (1) JPH0714867B2 (de)
AT (1) ATE87473T1 (de)
AU (2) AU7484887A (de)
CA (1) CA1305669C (de)
DE (1) DE3785136T2 (de)
WO (1) WO1987006829A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276060A (en) * 1979-06-19 1994-01-04 Block/Chemex, G.P. Methods of treating tumors with compositions of catecholic butanes
US5008294A (en) * 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
JPH01501790A (ja) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド リポキシゲナーゼ阻害剤
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5308874A (en) * 1992-06-26 1994-05-03 Vyrex Corporation Airborne protectants against oxidative tissue damage
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US20050020672A1 (en) * 1994-04-08 2005-01-27 The Procter & Gamble Company Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
US5627187A (en) * 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
US5631245A (en) 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
EP0938548B1 (de) 1996-11-06 2008-08-06 The Regents of the University of California Tumor necrosis factor rezeptor abspaltendes enzym, dessen zubereitungen und verwendungen
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AU8759298A (en) * 1997-10-06 1999-04-27 Shaman Pharmaceuticals, Inc. Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome
CA2319131A1 (en) 1998-01-26 1999-07-29 Walter H. Moos Mitochondria protecting agents for treating mitochondria associated diseases
EP1222920A3 (de) * 1998-01-26 2003-03-12 Mitokor Schutzmittel für Mitochondrien zur Behandlung von mitochondrialen Erkrankungen
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US20030082647A1 (en) * 2000-12-12 2003-05-01 Reenan Robert A. Transporter protein
US7118873B2 (en) 2000-12-12 2006-10-10 The University Of Connecticut Polynucleotides encoding cellular transporters and methods of use thereof
WO2010065567A2 (en) * 2008-12-01 2010-06-10 Lifespan Extension Llc Methods and compositions for altering health, wellbeing, and lifespan
US20110150856A1 (en) * 2009-12-21 2011-06-23 Sarah Bacus Compositions and methods for treatment of vitiligo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2644822A (en) * 1949-08-26 1953-07-07 Sulphite Products Corp 2, 3-bis-(oxybenzyl)-butane derivatives
FR3866M (fr) * 1964-07-08 1966-01-24 Rocal Médicament a base de dérivé du pyrocatéchol.
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
US4530844A (en) * 1984-07-26 1985-07-23 Warner-Lambert Company Synergistic non-steroidal anti-inflammatory compounds and compositions thereof

Also Published As

Publication number Publication date
EP0265514A1 (de) 1988-05-04
EP0265514B1 (de) 1993-03-31
JPH0714867B2 (ja) 1995-02-22
DE3785136T2 (de) 1993-08-05
AU645771B2 (en) 1994-01-27
CA1305669C (en) 1992-07-28
ATE87473T1 (de) 1993-04-15
AU7484887A (en) 1987-12-01
AU6930591A (en) 1991-03-28
EP0265514A4 (de) 1990-01-11
WO1987006829A1 (en) 1987-11-19
US4695590A (en) 1987-09-22
JPH01500120A (ja) 1989-01-19

Similar Documents

Publication Publication Date Title
DE3785136T2 (de) Arzneimittel zur inhibition von hautfalte.
JPS5412381A (en) N-alkylpiperidine derivative
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
ES449939A1 (es) Procedimiento para preparar sulfuro de difenilo sustituido.
ES480113A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
IE780279L (en) Imidazole derivatives
JPS6434978A (en) Benzimidazole derivative, manufacture and application to medicine
JPS5419969A (en) Proline derivative and its preparation
ES8708213A1 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
SE7412163L (de)
ES2007784A6 (es) Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
JPS53127466A (en) Thiocarbamate type heterocyclic compounds and its preparation
JPS5673024A (en) Antihyperlipemic agent
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS5430161A (en) 2-aminomethylbenzoxazoles and their pharmaceutically acceptable acid salts
JPS5436252A (en) Novel propano-anthracene derivatives and their preparation
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative